Charcot-Marie-Tooth type 2CC misdiagnosed as Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
CIDP
CMT2CC
Charcot-Marie-tooth
Conduction block
NEFH
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
03 Sep 2024
03 Sep 2024
Historique:
received:
27
06
2024
accepted:
21
08
2024
medline:
3
9
2024
pubmed:
3
9
2024
entrez:
2
9
2024
Statut:
aheadofprint
Résumé
Charcot-Marie-Tooth (CMT) is a heterogeneous group of genetic neuropathies and is typically characterized by distal muscle weakness, sensory loss, pes cavus and areflexia. Herein we describe a case of CMT2CC presenting with proximal muscle weakness and equivocal electrophysiological features, that was misdiagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP). A 30-year-old woman complained of proximal muscle weakness with difficulty climbing stairs. Neurological examination showed weakness in lower limb (LL) muscles, that was marked proximally and mild distally, and absence of deep tendon reflexes in the ankles. Nerve conduction studies (NCS) showed sensory-motor neuropathy with non-uniform NC velocity and a partial conduction block (CBs) in peroneal nerve and tibial nerves. Thus, a diagnosis of CIDP was entertained and the patient underwent ineffective treatment with intravenous immunoglobulins. At electrophysiological revaluation CB in peroneal nerve was undetectable as also distal CMAP had decreased whereas the CBs persisted in tibial nerves. Hypothesizing a hereditary neuropathy, we examined the proband's son, who presented mild weakness of distal and proximal muscles at lower limbs. Neurophysiological investigation showed findings consistent with an intermediate-axonal electrophysiological pattern. A targeted-NGS including 136 CMT genes showed the heterozygous frameshift mutation (c.3057dupG; p.K1020fs*43) in the NEFH gene, coding for the neurofilament heavy chain and causing CMT2CC. Diagnosis of a genetic neuropathy may be challenging when clinical features are atypical and/or electrophysiological features are misleading. The most common misdiagnosis is CIDP. Our report suggests that also CMT2CC patients with proximal muscle weakness and equivocal electrophysiological features might be misdiagnosed as CIDP.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Charcot-Marie-Tooth (CMT) is a heterogeneous group of genetic neuropathies and is typically characterized by distal muscle weakness, sensory loss, pes cavus and areflexia. Herein we describe a case of CMT2CC presenting with proximal muscle weakness and equivocal electrophysiological features, that was misdiagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP).
CASE REPORT
METHODS
A 30-year-old woman complained of proximal muscle weakness with difficulty climbing stairs. Neurological examination showed weakness in lower limb (LL) muscles, that was marked proximally and mild distally, and absence of deep tendon reflexes in the ankles. Nerve conduction studies (NCS) showed sensory-motor neuropathy with non-uniform NC velocity and a partial conduction block (CBs) in peroneal nerve and tibial nerves. Thus, a diagnosis of CIDP was entertained and the patient underwent ineffective treatment with intravenous immunoglobulins. At electrophysiological revaluation CB in peroneal nerve was undetectable as also distal CMAP had decreased whereas the CBs persisted in tibial nerves. Hypothesizing a hereditary neuropathy, we examined the proband's son, who presented mild weakness of distal and proximal muscles at lower limbs. Neurophysiological investigation showed findings consistent with an intermediate-axonal electrophysiological pattern. A targeted-NGS including 136 CMT genes showed the heterozygous frameshift mutation (c.3057dupG; p.K1020fs*43) in the NEFH gene, coding for the neurofilament heavy chain and causing CMT2CC.
INTERPRETATION
CONCLUSIONS
Diagnosis of a genetic neuropathy may be challenging when clinical features are atypical and/or electrophysiological features are misleading. The most common misdiagnosis is CIDP. Our report suggests that also CMT2CC patients with proximal muscle weakness and equivocal electrophysiological features might be misdiagnosed as CIDP.
Identifiants
pubmed: 39223423
doi: 10.1007/s10072-024-07747-7
pii: 10.1007/s10072-024-07747-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Fondazione Società Italiana di Neurologia.
Références
Pisciotta C, Shy ME (2023) Hereditary neuropathy. Handb Clin Neurol. ;195:609–617. https://doi.org/10.1016/B978-0-323-98818-6.00009-1 . PMID: 37562889
Pipis M, Cortese A, Polke JM, Poh R, Vandrovcova J, Laura M, Skorupinska M, Jacquier A, Juntas-Morales R, Latour P, Petiot P, Sole G, Fromes Y, Shah S, Blake J, Choi BO, Chung KW, Stojkovic T, Rossor AM, Reilly MM (2022) Charcot-Marie-tooth disease type 2CC due to NEFH variants causes a progressive, non-length-dependent, motor-predominant phenotype. J Neurol Neurosurg Psychiatry 93(1):48–56. https://doi.org/10.1136/jnnp-2021-327186 Epub 2021 Sep 13. PMID: 34518334; PMCID: PMC8685631
doi: 10.1136/jnnp-2021-327186
pubmed: 34518334
Aruta F, Severi D, Iovino A, Spina E, Barghigiani M, Ruggiero L, Iodice R, Santorelli FM, Manganelli F, Tozza S (2021) Proximal weakness involvement in the first Italian case of Charcot-Marie-tooth 2CC harboring a novel frameshift variant in NEFH. J Peripher Nerv Syst 26(2):231–234. https://doi.org/10.1111/jns.12454 Epub 2021 May 19. PMID: 33987933
doi: 10.1111/jns.12454
pubmed: 33987933
Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, Shaw CE, Powell JF, Leigh PN (1999) Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet. ;8(2):157 – 64. https://doi.org/10.1093/hmg/8.2.157 . PMID: 9931323
Lee MK, Xu Z, Wong PC, Cleveland DW (1993) Neurofilaments are obligate heteropolymers in vivo. J Cell Biol 122(6):1337–1350. https://doi.org/10.1083/jcb.122.6.1337 PMID: 8376466; PMCID: PMC2119859
doi: 10.1083/jcb.122.6.1337
pubmed: 8376466
Liu Q, Xie F, Siedlak SL, Nunomura A, Honda K, Moreira PI, Zhua X, Smith MA, Perry G (2004) Neurofilament proteins in neurodegenerative diseases. Cell Mol Life Sci. ;61(24):3057-75. https://doi.org/10.1007/s00018-004-4268-8 . PMID: 15583867
Nixon RA, Shea TB (1992) Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motil Cytoskeleton. ;22(2):81–91. https://doi.org/10.1002/cm.970220202 . PMID: 1633625
Bian X, Lin P, Li J, Long F, Duan R, Yuan Q, Li Y, Gao F, Gao S, Wei S, Li X, Sun W, Gong Y, Yan C, Liu Q (2018) Whole-genome linkage analysis with whole-exome sequencing identifies a novel frameshift variant in NEFH in a Chinese family with Charcot-Marie-tooth 2: a novel variant in NEFH for Charcot-Marie-tooth 2. Neurodegener Dis 18(2–3):74–83. https://doi.org/10.1159/000487754 Epub 2018 Mar 27. PMID: 29587262
doi: 10.1159/000487754
pubmed: 29587262
Rebelo AP, Abrams AJ, Cottenie E, Horga A, Gonzalez M, Bis DM, Sanchez-Mejias A, Pinto M, Buglo E, Markel K, Prince J, Laura M, Houlden H, Blake J, Woodward C, Sweeney MG, Holton JL, Hanna M, Dallman JE, Auer-Grumbach M, Reilly MM, Zuchner S (2016) Cryptic amyloidogenic elements in the 3’ UTRs of neurofilament genes trigger Axonal Neuropathy. Am J Hum Genet 98(4):597–614 Epub 2016 Mar 31. PMID: 27040688; PMCID: PMC4833435
doi: 10.1016/j.ajhg.2016.02.022
pubmed: 27040688
pmcid: 4833435
Jacquier A, Delorme C, Belotti E, Juntas-Morales R, Solé G, Dubourg O, Giroux M, Maurage CA, Castellani V, Rebelo A, Abrams A, Züchner S, Stojkovic T, Schaeffer L, Latour P (2017) Cryptic amyloidogenic elements in mutant NEFH causing Charcot-Marie-tooth 2 trigger aggresome formation and neuronal death. Acta Neuropathol Commun 5(1):55. https://doi.org/10.1186/s40478-017-0457-1 PMID: 28709447; PMCID: PMC5513089
doi: 10.1186/s40478-017-0457-1
pubmed: 28709447
pmcid: 5513089
Peter YK, Van den Bergh RDM, Hadden P, Bouche (2010) European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the peripheral nerve society - first revision. J Peripher Nerv Syst 15:1–9
doi: 10.1111/j.1529-8027.2010.00245.x
Chen Z, Saini M, Neo SXM, Ng PS, Koh JS, Prasad K, Verma K, Davila S, Lim WK, Phua Z, Li MM, Kang C, Tay KSS, Chai JYH (2022) Acute to Subacute Atraumatic Entrapment neuropathies in patients with CMT1A: a report of a distinct phenotypic variant of CMT1A. Front Neurol 13:826634. https://doi.org/10.3389/fneur.2022.826634 PMID: 35280294; PMCID: PMC8914073
doi: 10.3389/fneur.2022.826634
pubmed: 35280294
pmcid: 8914073
Yuan A, Rao MV, Veeranna, Nixon RA (2012) Neurofilaments at a glance. J Cell Sci 125(Pt 14):3257–3263. https://doi.org/10.1242/jcs.104729 PMID: 22956720; PMCID: PMC3516374
doi: 10.1242/jcs.104729
pubmed: 22956720
pmcid: 3516374
Fabrizi GM, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G, Bertolasi L, Rizzuto N (2007) Charcot-Marie-tooth disease type 2E, a disorder of the cytoskeleton. Brain 130(Pt 2):394–403. https://doi.org/10.1093/brain/awl284 Epub 2006 Oct 18. PMID: 17052987
doi: 10.1093/brain/awl284
pubmed: 17052987
Pisciotta C, Bai Y, Brennan KM, Wu X, Grider T, Feely S, Wang S, Moore S, Siskind C, Gonzalez M, Zuchner S, Shy ME (2015) Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E. Neurology 85(3):228–234 Epub 2015 Jun 24. PMID: 26109717; PMCID: PMC4516296
doi: 10.1212/WNL.0000000000001773
pubmed: 26109717
pmcid: 4516296